Université Paris-Sud Faculté de Pharmacie CNRS INSERM

Rechercher



décembre 2022 :

Rien pour ce mois

novembre 2022 | janvier 2023


Accueil > Plateformes > CIBLOT

Publications

Nicolas C, Shittl J, Pertuiset C, Mehel H, Courilleau D, Jullian JC, Cresteil T, Blondeau JP, Colas C, Iorga B, Gueritte F, Gernigon N, Cintrat JC, Ambroise Y, Sylla M, Neveu N, Dumas F, Vandecasteele G, Fischmeister R, Brenner C. Assay development and high-throughput screening to identify PDE2A activators to treat heart failure. Arch Cardiovasc Dis Supplements. (2014) 6, 43.


Courilleau D, Bouyssou P, Fischmeister R, Lezoualc’h F, Blondeau JP. The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1). Biochem Biophys Res Commun. (2013) 440(3), 443-8.


Courilleau D, Bisserier M, Jullian J-C, Lucas A, Bouyssou P, Fischmeister R, Blondeau J-P, Lezoualc’h F. Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac. J Biol Chem. (2012) 287, 44192-44202.


Ruiz M, Courilleau D, Jullian JC, Fortin D, Ventura-Clapier R, Blondeau JP, Garnier A. A cardiac-specific robotized cellular assay identified families of human ligands as inducers of PGC-1 ? expression and mitochondrial biogenesis. PLoS One (2012), 7, 10.


Lévy-Bimbot M, Major G, Courilleau D, Blondeau JP, Lévi Y. Tetrabromobisphenol-A disrupts thyroid hormone receptor alpha function in vitro : Use of fluorescence polarization to assay corepressor and coactivator peptide binding. Chemosphere (2012) 87, 782-788.